meningeal metastasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1). Age =18 years old, gender unlimited. 2). Pathological/cytological diagnosis of non-small cell lung cancer. 3) Meningeal metastatic carcinoma was confirmed by cerebrospinal fluid cytology at the time of treatment; Meningeal metastases occur at any stage of the disease. 4). Whether or not accompanied by other parts of the transfer. 5) Patients who agree to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1). Refused to be included in the study or refused to cooperate with the interviewers; 2) The investigator determines that the patient is not suitable to participate in the real-world clinical study, including but not limited to the following circumstances: poor patient cooperation, poor family cooperation, and overseas travel.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year survival rate; | — |
Countries
China
Contacts
Huashan Hospital,Fudan University